Eton Pharmaceuticals Inc
NASDAQ:ETON

Watchlist Manager
Eton Pharmaceuticals Inc Logo
Eton Pharmaceuticals Inc
NASDAQ:ETON
Watchlist
Price: 11.23 USD 4.47% Market Closed
Market Cap: 290.2m USD
Have any thoughts about
Eton Pharmaceuticals Inc?
Write Note

Intrinsic Value

The intrinsic value of one ETON stock under the Base Case scenario is 12.15 USD. Compared to the current market price of 11.23 USD, Eton Pharmaceuticals Inc is Undervalued by 8%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ETON Intrinsic Value
12.15 USD
Undervaluation 8%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Eton Pharmaceuticals Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for ETON cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about ETON?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Eton Pharmaceuticals Inc

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Eton Pharmaceuticals Inc

Provide an overview of the primary business activities
of Eton Pharmaceuticals Inc.

What unique competitive advantages
does Eton Pharmaceuticals Inc hold over its rivals?

What risks and challenges
does Eton Pharmaceuticals Inc face in the near future?

Has there been any significant insider trading activity
in Eton Pharmaceuticals Inc recently?

Summarize the latest earnings call
of Eton Pharmaceuticals Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Eton Pharmaceuticals Inc.

Provide P/S
for Eton Pharmaceuticals Inc.

Provide P/E
for Eton Pharmaceuticals Inc.

Provide P/OCF
for Eton Pharmaceuticals Inc.

Provide P/FCFE
for Eton Pharmaceuticals Inc.

Provide P/B
for Eton Pharmaceuticals Inc.

Provide EV/S
for Eton Pharmaceuticals Inc.

Provide EV/GP
for Eton Pharmaceuticals Inc.

Provide EV/EBITDA
for Eton Pharmaceuticals Inc.

Provide EV/EBIT
for Eton Pharmaceuticals Inc.

Provide EV/OCF
for Eton Pharmaceuticals Inc.

Provide EV/FCFF
for Eton Pharmaceuticals Inc.

Provide EV/IC
for Eton Pharmaceuticals Inc.

Show me price targets
for Eton Pharmaceuticals Inc made by professional analysts.

What are the Revenue projections
for Eton Pharmaceuticals Inc?

How accurate were the past Revenue estimates
for Eton Pharmaceuticals Inc?

What are the Net Income projections
for Eton Pharmaceuticals Inc?

How accurate were the past Net Income estimates
for Eton Pharmaceuticals Inc?

What are the EPS projections
for Eton Pharmaceuticals Inc?

How accurate were the past EPS estimates
for Eton Pharmaceuticals Inc?

What are the EBIT projections
for Eton Pharmaceuticals Inc?

How accurate were the past EBIT estimates
for Eton Pharmaceuticals Inc?

Compare the revenue forecasts
for Eton Pharmaceuticals Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Eton Pharmaceuticals Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Eton Pharmaceuticals Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Eton Pharmaceuticals Inc compared to its peers.

Compare the P/E ratios
of Eton Pharmaceuticals Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Eton Pharmaceuticals Inc with its peers.

Analyze the financial leverage
of Eton Pharmaceuticals Inc compared to its main competitors.

Show all profitability ratios
for Eton Pharmaceuticals Inc.

Provide ROE
for Eton Pharmaceuticals Inc.

Provide ROA
for Eton Pharmaceuticals Inc.

Provide ROIC
for Eton Pharmaceuticals Inc.

Provide ROCE
for Eton Pharmaceuticals Inc.

Provide Gross Margin
for Eton Pharmaceuticals Inc.

Provide Operating Margin
for Eton Pharmaceuticals Inc.

Provide Net Margin
for Eton Pharmaceuticals Inc.

Provide FCF Margin
for Eton Pharmaceuticals Inc.

Show all solvency ratios
for Eton Pharmaceuticals Inc.

Provide D/E Ratio
for Eton Pharmaceuticals Inc.

Provide D/A Ratio
for Eton Pharmaceuticals Inc.

Provide Interest Coverage Ratio
for Eton Pharmaceuticals Inc.

Provide Altman Z-Score Ratio
for Eton Pharmaceuticals Inc.

Provide Quick Ratio
for Eton Pharmaceuticals Inc.

Provide Current Ratio
for Eton Pharmaceuticals Inc.

Provide Cash Ratio
for Eton Pharmaceuticals Inc.

What is the historical Revenue growth
over the last 5 years for Eton Pharmaceuticals Inc?

What is the historical Net Income growth
over the last 5 years for Eton Pharmaceuticals Inc?

What is the current Free Cash Flow
of Eton Pharmaceuticals Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Eton Pharmaceuticals Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Eton Pharmaceuticals Inc

Current Assets 29.7m
Cash & Short-Term Investments 20.3m
Receivables 5.6m
Other Current Assets 3.9m
Non-Current Assets 6.1m
PP&E 226k
Intangibles 5.9m
Other Non-Current Assets 12k
Current Liabilities 19.7m
Accounts Payable 2.7m
Accrued Liabilities 12.9m
Other Current Liabilities 4.1m
Non-Current Liabilities 126k
Other Non-Current Liabilities 126k
Efficiency

Earnings Waterfall
Eton Pharmaceuticals Inc

Revenue
34.7m USD
Cost of Revenue
-14.1m USD
Gross Profit
20.6m USD
Operating Expenses
-25.8m USD
Operating Income
-5.2m USD
Other Expenses
-262k USD
Net Income
-5.5m USD

Free Cash Flow Analysis
Eton Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

ETON Profitability Score
Profitability Due Diligence

Eton Pharmaceuticals Inc's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
Exceptional 3-Years Revenue Growth
ROE is Increasing
33/100
Profitability
Score

Eton Pharmaceuticals Inc's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

ETON Solvency Score
Solvency Due Diligence

Eton Pharmaceuticals Inc's solvency score is 41/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
41/100
Solvency
Score

Eton Pharmaceuticals Inc's solvency score is 41/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ETON Price Targets Summary
Eton Pharmaceuticals Inc

Wall Street analysts forecast ETON stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ETON is 13.26 USD with a low forecast of 11.11 USD and a high forecast of 15.75 USD.

Lowest
Price Target
11.11 USD
1% Downside
Average
Price Target
13.26 USD
18% Upside
Highest
Price Target
15.75 USD
40% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ETON?

Click here to dive deeper.

Dividends

Eton Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ETON is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

ETON Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Eton Pharmaceuticals Inc Logo
Eton Pharmaceuticals Inc

Country

United States of America

Industry

Pharmaceuticals

Market Cap

290.1m USD

Dividend Yield

0%

Description

Eton Pharmaceuticals, Inc. engages in the development, acquisition, and commercialization of prescription drug products. The company is headquartered in Deer Park, Illinois and currently employs 17 full-time employees. The company went IPO on 2018-11-09. Eton is primarily focused on hospital injectable and pediatric rare disease products. The Company’s Biorphen product is an alpha-1 adrenergic receptor agonist indicated for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia. Its Alkindi Sprinkle product is a replacement therapy for pediatric adrenal insufficiency (AI), including congenital adrenal hyperplasia (CAH) in patients from birth to less than 17 years of age. Its product pipeline includes Zonisamide Oral liquid, Topiramate Oral Solution, Cysteine Injection, Dehydrated Alcohol Injection, Ephedrine Injection and Lamotrigine Oral Suspension. The firm's product candidates are primarily focused on two core areas: hospital-based products and pediatric oral liquid products.

Contact

ILLINOIS
Deer Park
21925 W Field Pkwy Ste 235
+18477877361.0
etonpharma.com

IPO

2018-11-09

Employees

17

Officers

President, CEO & Director
Mr. Sean E. Brynjelsen
CFO, Treasurer & Secretary
Mr. James R. Gruber CPA
Chief Business Officer
Mr. David C. Krempa
Senior Vice President of Quality & Operations
Danka Radosavljevic
Vice President of Sales Operations
Mr. Scott Grossenbach
Executive VP of Commercial Operations
Mr. Kevin Guthrie

See Also

Discover More
What is the Intrinsic Value of one ETON stock?

The intrinsic value of one ETON stock under the Base Case scenario is 12.15 USD.

Is ETON stock undervalued or overvalued?

Compared to the current market price of 11.23 USD, Eton Pharmaceuticals Inc is Undervalued by 8%.

Back to Top